Deferoxamine Mesylate

   
Google
 
Web NewDrugInformation.com

Deferoxamine Mesylate


Drug - Deferoxamine Mesylate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Deferoxamine Mesylate
Multiple ingredients are in alphabetical order.

Strength - 500MG/VIAL
The potency of the active ingredient(s), Deferoxamine Mesylate. May repeat for multiple part products.

Applicant - HOSPIRA
The firm name holding legal responsibility for Deferoxamine Mesylate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076019
The FDA assigned number to Deferoxamine Mesylate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Deferoxamine Mesylate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 17, 2004
The date Deferoxamine Mesylate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Deferoxamine Mesylate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Deferoxamine Mesylate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hospira Inc
The full name of the firm holding legal responsibility for the new application of Deferoxamine Mesylate.

Deferoxamine Mesylate